‘Life saving’ drug for people with opioid dependency to be pulled from Australia by end of year
•Exclusive: Fears that US companies may withdraw more medecines as global markets react to policy changes by the Trump administrationA “life saving” drug heavily subsidised for Australians living with...
هذا الخبر من The Guardian. خبر يقدم أدوات ذكاء اصطناعي للتلخيص والترجمة والاستماع.
المصدر: The Guardian | Source: The GuardianExclusive: Fears that US companies may withdraw more medecines as global markets react to policy changes by the Trump administration
A “life saving” drug heavily subsidised for Australians living with opioid dependency will be pulled from the market by the end of the year, causing alarm among doctors and pharmacists.
US pharmaceutical company Indivior confirmed the marketing and sale of the long-acting injectable prescription opioid Sublocade would end from 31 December, with a company spokesperson describing it as a “commercial decision”.
Continue reading...
ملاحظة تحريرية | Editorial Note: نُشر هذا المقال في الأصل بواسطة The Guardian. خبر (Khabr) هي منصة إعلامية أردنية مرخّصة تعمل بالذكاء الاصطناعي. نضيف قيمة تحريرية من خلال: تحليل ذكي للأخبار، ملخصات تلقائية، رواية صوتية بالذكاء الاصطناعي، ترجمة متعددة اللغات، وتدقيق الحقائق. هدفنا جعل الأخبار أكثر وضوحاً وسهولةً للقارئ العربي.
This article was originally published by The Guardian. Khabr is a licensed Jordanian AI-powered news platform (Registration #82086). We add editorial value through: AI-powered news analysis, automated summaries, AI audio narration, multi-language translation (Arabic, English, French, Turkish), and AI fact-checking. Our mission is to make news more accessible and understandable for Arabic-speaking audiences worldwide.
